Compare HUBS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUBS | DGX |
|---|---|---|
| Founded | 2005 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8B | 20.5B |
| IPO Year | 2014 | 1996 |
| Metric | HUBS | DGX |
|---|---|---|
| Price | $398.12 | $176.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 30 | 13 |
| Target Price | ★ $618.53 | $196.69 |
| AVG Volume (30 Days) | 790.9K | ★ 1.1M |
| Earning Date | 02-11-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.82% |
| EPS Growth | N/A | ★ 14.49 |
| EPS | N/A | ★ 8.51 |
| Revenue | $2,987,698,000.00 | ★ $10,850,000,000.00 |
| Revenue This Year | $20.84 | $12.37 |
| Revenue Next Year | $16.03 | $3.52 |
| P/E Ratio | ★ N/A | $20.68 |
| Revenue Growth | ★ 19.21 | 13.74 |
| 52 Week Low | $344.41 | $148.70 |
| 52 Week High | $881.13 | $197.55 |
| Indicator | HUBS | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 54.92 | 37.28 |
| Support Level | $381.46 | $174.59 |
| Resistance Level | $405.00 | $179.80 |
| Average True Range (ATR) | 13.02 | 2.70 |
| MACD | 4.74 | -0.84 |
| Stochastic Oscillator | 84.57 | 16.66 |
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.